Guanhao Biotech Co.,Ltd. (SHE:300238)
10.95
+0.65 (6.31%)
Nov 5, 2026, 3:04 PM CST
Guanhao Biotech Revenue
Guanhao Biotech had revenue of 76.07M CNY in the quarter ending September 30, 2026, a decrease of -17.86%. This brings the company's total for the last twelve months to 344.85M, down -12.21% year-over-year. In the year 2025, Guanhao Biotech had annual revenue of 387.75M with 2.72% growth. That makes Guanhao Biotech the 27,761st largest company in the world by revenue and 4,786th in China.
Revenue (ttm)
344.85M
Revenue Growth
-12.21%
P/S Ratio
8.72
Revenue / Employee
644.58K
Employees
535
Market Cap
3.01B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 387.75M | 10.27M | 2.72% |
| Dec 31, 2024 | 377.48M | -26.70M | -6.60% |
| Dec 31, 2023 | 404.18M | 26.89M | 7.13% |
| Jan 1, 2023 | 377.29M | -111.70M | -22.84% |
| Jan 1, 2022 | 488.98M | 52.02M | 11.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xiangxue Pharmaceutical | 1.51B |
| Qingdao Vland Biotech INC. | 1.45B |
| Kexing Biopharm | 1.30B |
| Beijing Kawin Technology Share-Holding | 1.21B |
| Pulike Biological Engineering | 1.00B |
| Hubei Goto Biopharm Group | 665.71M |
| Zhejiang Shouxiangu Pharmaceutical | 590.94M |
| Lifecome Biochemistry | 453.12M |